MAPT and Alzheimer disease: Considering the clinical manifestations, the results of the brain MRI, and CSF levels of Aβ42, P-tau, and T-tau, the patient was diagnosed with AD, with parkinsonian and psychiatric features (Fig. 1A, 1C).